NasdaqGM - Delayed Quote USD
Alvotech (ALVOW)
1.4200
+0.0200
+(1.43%)
At close: April 24 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-236,843
-236,843
-312,185
-312,389
-228,170
Investing Cash Flow
-18,868
-18,868
-46,340
-63,537
-40,633
Financing Cash Flow
297,306
297,306
301,319
424,910
254,831
End Cash Position
51,428
51,428
11,157
66,427
17,556
Capital Expenditure
-57,000
-57,000
-46,473
-49,002
-40,633
Issuance of Capital Stock
150,451
150,451
136,879
9,827
185,856
Issuance of Debt
920,763
920,763
278,831
353,678
113,821
Repayment of Debt
-768,779
-768,779
-107,636
-95,861
-44,846
Free Cash Flow
-293,843
-293,843
-358,658
-361,391
-268,803
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SEQUENT.BO Sequent Scientific Limited
148.20
-3.67%
SHILPAMED.BO Shilpa Medicare Limited
682.55
-5.52%
NEULANDLAB.BO Neuland Laboratories Limited
12,300.60
-5.99%
LAURUSLABS.BO Laurus Labs Limited
625.40
-3.36%
RDY Dr. Reddy's Laboratories Limited
13.79
-1.50%
TEVA Teva Pharmaceutical Industries Limited
14.87
+1.02%